Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH) | Zendy

Ilka Ott | Zendy; Salvatore Cassese | Zendy; Philipp Groha | Zendy; Birgit Steppich | Zendy; Martin Hadamitzky | Zendy; Tareq Ibrahim | Zendy; Sebastian Kufner | Zendy; Karl Dewitz | Zendy; Regina Hiendlmayer | Zendy; KarlLudwig Laugwitz | Zendy; Heribert Schunkert | Zendy; Adnan Kastrati | Zendy; Massimiliano Fusaro | Zendy

Open Access

Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH)

Author(s) -

Ilka Ott,

Salvatore Cassese,

Philipp Groha,

Birgit Steppich,

Martin Hadamitzky,

Tareq Ibrahim,

Sebastian Kufner,

Karl Dewitz,

Regina Hiendlmayer,

KarlLudwig Laugwitz,

Heribert Schunkert,

Adnan Kastrati,

Massimiliano Fusaro

Publication year - 2017

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.116.025329

Subject(s) - medicine , angioplasty , restenosis , balloon , stenosis , atherectomy , radiology , revascularization , angiography , surgery , stent , cardiology , myocardial infarction

Atherosclerosis in the superficial femoral artery is common in patients suffering from peripheral artery disease. Paclitaxel-eluting balloon (PEB) angioplasty, stenting, and directional atherectomy (DA) have provided new options for the treatment of superficial femoral artery disease; however, the comparative efficacy of these interventional strategies remains uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research